Cetuximab Inhibits the Growth of Mucinous Ovarian Carcinoma Tumor Cells Lacking KRAS Gene Mutations

Oncology Reports - Greece
doi 10.3892/or.2012.1626
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Status of Her2 Amplification and Kras Mutations in Mucinous Ovarian Carcinoma

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Multipoint Kras Oncogene Mutations Potentially Indicate Mucinous Carcinoma on the Entire Spectrum of Mucinous Ovarian Neoplasms

Oncotarget
Oncology
2016English

Expression of C-Myc and Mutation of the KRAS Gene in Patients With Ovarian Mucinous Tumors

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Tumor-Specific Delivery of KRAS siRNA With iRGD-exosomes Efficiently Inhibits Tumor Growth

ExRNA
2019English

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma

Journal of the American College of Surgeons
Surgery
2015English

Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression

Anticancer Research
MedicineCancer ResearchOncology
2017English

Susd2/Susd2, a Putative Tumor Suppressor Gene, Inhibits Growth of Colorectal Cancer Cells

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2018English

Pancreatic Cancer: Circulating Tumor Cells and Primary Tumors Show Heterogeneous KRAS Mutations

Scientific Reports
Multidisciplinary
2017English

The Candidate Tumor Suppressor Gene ECRG4 Inhibits Cancer Cells Migration and Invasion in Esophageal Carcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy